I'm on business <a href="http://highlightconseil.com/" rel="nofollow">legal preteen lolita site</a>  The drugmaker's immunotherapy drug Yervoy failed tosignificantly prolong survival among patients with advancedprostate cancer who had previously received chemotherapy,according to limited data from the first late-stage study of thedrug for the condition. (Compiled by Varun Aggarwal; Editing by Don Sebastian)